| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6077836 | BAXTER HLTHCARE | Peritoneal dialysis and compositions for use therein |
Jun, 2017
(6 years ago) | |
| US6248726 | BAXTER HLTHCARE | Method of peritoneal dialysis using glucose polymer solutions |
Jun, 2018
(5 years ago) | |
Extraneal is owned by Baxter Hlthcare.
Extraneal contains Icodextrin.
Extraneal has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Extraneal are:
- US6077836
- US6248726
Extraneal was authorised for market use on 20 December, 2002.
Extraneal is available in solution;intraperitoneal dosage forms.
Extraneal can be used as peritoneal dialysis solution.
The generics of Extraneal are possible to be released after 19 June, 2018.
Drugs and Companies using ICODEXTRIN ingredient
Market Authorisation Date: 20 December, 2002
Treatment: Peritoneal dialysis solution
Dosage: SOLUTION;INTRAPERITONEAL
More Information on Dosage
EXTRANEAL family patents
